Evidence map›Paper›PMID 36259943›Full record

ArticleBrain and behavior2022

A retrospective case series of electroconvulsive therapy in the management of depression and suicidal symptoms in adolescents.

Xiaolu Chen, Yixiao Fu, Qianhong Zou, Yiting Zhang, Xiaoyue Qin, Yu Tian, Yu Yan, Qibin Chen, Lei Zou, Bangshu Zhao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Xiaolu ChenThe First Branch, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yixiao FuDepartment of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qianhong ZouDepartment of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.
Yiting ZhangDepartment of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.
Xiaoyue QinDepartment of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.
Yu TianDepartment of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.
Yu YanInformation Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qibin ChenDepartment of Anesthesiology, The First Affiliated Hospital of Chongqing Medical, University, Chongqing, China.
Lei ZouDepartment of Anesthesiology, The First Affiliated Hospital of Chongqing Medical, University, Chongqing, China.ORCID 0000-0003-3247-6006
Bangshu ZhaoDepartment of Anesthesiology, The First Affiliated Hospital of Chongqing Medical, University, Chongqing, China.
Xiao LiDepartment of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0002-6120-3800
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMajor depressive disorder (MDD) with suicidal symptoms is common in adolescents. Electroconvulsive therapy (ECT) is highly effective in the treatment of MDD. We have described its use and outcome in a case series of adolescents with depression and suicidal symptoms receiving ECT.

methodsWe analyzed 362 adolescents aged from 12 to 17 who had received ECT between year 2015 and 2021. A total of 278 subjects were found to meet the inclusion criteria, where depressive symptoms were assessed by HDRS and suicidal symptoms were assessed by HDRS item 3. Their sociodemographic, clinical, and treatment information were retrieved through these records for this study.

resultsThe mean ± SD age of subjects was 15.41 ± 1.50 years and male sex was 14.7% (n = 41). Comorbid diagnoses were present in 104 patients (37.4%). The ECT sessions ranged from 6 to 12 times. All the patients took antidepressants, with sertraline (n = 182; 65.5%) being the most widely used. Majority of patients also received benzodiazepines. ECT was significantly effective in adolescents with depression and suicidal symptoms in evaluation by HDRS, HDRS item 3, CGI-S (p < .001) pre/post-ECT. The response rate of MDD patients was 52%, with suicidal ideation (SI) at 49%, and 54% in MDD with suicide attempt (SA). The change of CGI-S scores showed no significant differences between various subgroups of sex and comorbid (p>.05), but there were significant differences between subgroups of suicidal symptoms (p < .001). ECT was generally safe with subjective memory complaint (n = 189, 68.0%), headache (n = 150, 54.0%), body pain (n = 28, 10.1%), delirium (n = 95, 34.2%), and nausea (n = 31, 11.2%) as possible side effects following ECT.

conclusionIn this study, ECT was found to decrease depressive and suicidal symptoms in adolescents, and the side effect was acceptable. ECT showed better outcome for MDD with SA compared to MDD with SI.

Indexed as

Electroconvulsive TherapyMajor Depressive DisorderAdolescentDepressionHumansMaleRetrospective StudiesSuicidal IdeationTreatment Outcomeadolescentsdepressionefficacyelectroconvulsive therapy (ECT)side effectsuicide

Identifiers

PMID36259943
PMCPMC9660487
OpenAlexW4306831135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.